 SAN DIEGO, Oct. 30, 2020 PRNewswire -- Mirati Therapeutics, Inc. Nasdaq: MRTX today announced the closing of its previously announced underwritten public offering of 4,985,706 shares of its common stock at a public offering price of 202.00 per share, which consists of 4,585,706... 